Meeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5514 Citation: J Clin Oncol 35, 2017 (suppl; abstr 5514) Authors: Jan H.M. Schellens, Aurelien Marabelle, Susan Zeigenfuss, et. al. Background: In the phase 1b KEYNOTE-028 study, pembrolizumab showed promising activity as monotherapy in patients with advanced cervical cancers that...
Pro zobrazení tohoto obsahu je třeba být přihlášen.